Market-Moving News for May 21st
Market-Moving News for May 21st
BDRX: 110% | Biodexa Pharmaceuticals Presents Phase 2 Clinical Trial Results Of Its Newly-Licensed eRapa In Familial Adenomatous Polyposis Scheduled For Presentation At The 2024 Digestive Disease Week Annual Meeting; Reports Overall 83% Non-Progression Rate At 6 Months
BDRX：110% | Biodexa Pharmicals公佈了其新獲得許可的家族性腺瘤性息肉病eRapa的2期臨床試驗結果，該結果計劃在2024年消化系統疾病週年會上公佈；報告稱，6個月的總體非進展率爲83％
MMAT: 95% | Meta Materials shares are trading higher after the company announced that lawyers concluded that it has meritorious claims for market manipulation against several parties.
MMAT：95% | Meta Materials的股價走高，此前該公司宣佈律師得出結論，對多方提出了合理的市場操縱指控。
SPT: -11% | Sprout Social shares are trading lower after the company said there is no process in place to sell or take the Company private.
SPT：-11％ | Sprout Social的股價走低，此前該公司表示尚未制定出售或私有化的程序。
譯文內容由第三人軟體翻譯。